Mark Baldry
Corporate Officer/Principal at X4 PHARMACEUTICALS, INC.
Net worth: 27 900 $ as of 2024-04-29
Mark Baldry active positions
Companies | Position | Start | End |
---|---|---|---|
X4 PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-11-25 | - |
Career history of Mark Baldry
Former positions of Mark Baldry
Companies | Position | Start | End |
---|---|---|---|
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Corporate Officer/Principal | 2019-07-31 | 2020-01-31 |
AMICUS THERAPEUTICS, INC. | Sales & Marketing | 2015-06-07 | 2019-06-30 |
BIOGEN INC. | Public Communications Contact | - | 2015-04-30 |
FREELINE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 2020-11-01 | - |
WAVE LIFE SCIENCES LTD. | Corporate Officer/Principal | 2019-08-05 | - |
SHIRE | Corporate Officer/Principal | - | - |
Training of Mark Baldry
Concordia University | Masters Business Admin |
York University | Undergraduate Degree |
Statistics
International
United States | 5 |
United Kingdom | 3 |
Canada | 3 |
Operational
Corporate Officer/Principal | 5 |
Sales & Marketing | 1 |
Public Communications Contact | 1 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Utilities | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
BIOGEN INC. | Health Technology |
WAVE LIFE SCIENCES LTD. | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Utilities |
- Stock Market
- Insiders
- Mark Baldry
- Experience